title: The role of adenosine receptors in the central action of caffeine.
abstract: The behavioral effects of caffeine appear likely to be due in large measure to antagonism of the action of endogenous adenosine at A1- and A2a-receptors in the central nervous system. Other biochemical mechanisms of action of caffeine, such as release of intracellular calcium, inhibition of phosphodiesterases and blockade of regulatory sites of GABAA-reccptors, would require much higher concentrations than the micromolar concentrations of caffeine associated with behavioral stimulation. However, micromolar concentrations of caffeine also would be expected to cause only a modest blockade of adenosine receptors. Selective adenosine agonists and xanthine antagonists have provided some insights into central roles for adenosine receptor subtypes. Thus, behavioral stimulation by xanthines appears to require blockade of both A1- and A2a-receptors. Chronic blockade of adenosine receptors by caffeine would be expected to result in alterations in the central receptors and pathways that are regulated by adenosine through A1- and A2a-receptors. Indeed, chronic caffeine docs alter the density not only of adenosine receptors, but also of adrenergic, cholinergic, GABAergic and serotonergic receptors. Behavioral responses to agents acting through dopaminergic and cholinergic pathways arc altered. As yet, a coherent explanation of the acute and chronic effects of caffeine in terms of blockade of adenosine receptors has not emerged. Interactions between pathways subserved by A1- and A2a-adcnosine receptors complicate attempts to interpret caffeine pharmacology, as does the complex control by adenosine receptors of dopamincrgic, cholinergic and other central pathways.
authors.affiliation: National Institute of Health, Bethesda, Maryland.
authors.forename: John W
authors.initials: JW
authors.lastname: Daly
authors.affiliation: National Institute of Health, Bethesda, Maryland.
authors.forename: Dan
authors.initials: D
authors.lastname: Shi
authors.forename: Olga
authors.initials: O
authors.lastname: Nikodijevic
authors.affiliation: National Institute of Health, Bethesda, Maryland.
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Jacobson
keywords: Adenosine receptors; Amphetamine; Calcium storage; Cocaine; Dopamine; Muscarinic antagonists; Nicotine; Phosphodiesterase
references.citation: J Pharmacol Exp Ther. 1993 Sep;266(3):1563-72
references.pmid: 8371158
references.citation: Pharmacol Biochem Behav. 1988 Jan;29(1):63-6
references.pmid: 3353432
references.citation: J Pharmacol Exp Ther. 1991 Oct;259(1):286-94
references.pmid: 1920121
references.citation: Drug Dev Res. 1993 Oct;30(2):104-110
references.pmid: 38250653
references.citation: Pharmacol Biochem Behav. 1991 Sep;40(1):121-3
references.pmid: 1780334
references.citation: Eur J Pharmacol. 1982 Aug 13;82(1-2):113-4
references.pmid: 6290230
references.citation: Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7238-41
references.pmid: 1678519
references.citation: J Pharmacol Exp Ther. 1991 Jan;256(1):62-8
references.pmid: 1846425
references.citation: Eur J Pharmacol. 1989 Sep 22;168(3):285-90
references.pmid: 2583238
references.citation: J Pharmacol Exp Ther. 1988 Jan;244(1):218-25
references.pmid: 3335999
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):407-14
references.pmid: 8510768
references.citation: Life Sci. 1979 Feb 26;24(9):851-7
references.pmid: 449624
references.citation: Arch Int Pharmacodyn Ther. 1994 Nov-Dec;328(3):261-87
references.pmid: 7625882
references.citation: Pharmacol Biochem Behav. 1986 Feb;24(2):263-70
references.pmid: 2419924
references.citation: Neuron. 1991 Jul;7(1):17-25
references.pmid: 1648939
references.citation: Brain Res. 1984 Feb 27;294(1):186-9
references.pmid: 6697237
references.citation: Life Sci. 1986 Feb 17;38(7):577-88
references.pmid: 3003486
references.citation: Acta Physiol Scand. 1984 Sep;122(1):55-9
references.pmid: 6095597
references.citation: Pharmacol Biochem Behav. 1993 Jan;44(1):199-216
references.pmid: 7679219
references.citation: Neurosci Lett. 1982 Jul 20;31(1):47-52
references.pmid: 6289200
references.citation: Brain Res Brain Res Rev. 1992 May-Aug;17(2):139-70
references.pmid: 1356551
references.citation: Brain Res. 1994 Jul 4;650(1):153-6
references.pmid: 7953667
references.citation: Gen Pharmacol. 1986;17(4):501-3
references.pmid: 3019827
references.citation: Epilepsia. 1989 Jan-Feb;30(1):26-33
references.pmid: 2912715
references.citation: Pharmacol Biochem Behav. 1990 Feb;35(2):477-9
references.pmid: 2320659
references.citation: Life Sci. 1988;43(5):387-98
references.pmid: 2456442
references.citation: Acta Physiol Scand. 1982 Jun;115(2):283-6
references.pmid: 6291335
references.citation: Biochem Pharmacol. 1993 Nov 17;46(10):1825-9
references.pmid: 8250969
references.citation: Pharmacol Biochem Behav. 1994 Jan;47(1):89-94
references.pmid: 7906891
references.citation: Cell Mol Neurobiol. 1993 Jun;13(3):247-61
references.pmid: 8242688
references.citation: Brain Res Bull. 1988 Sep;21(3):479-82
references.pmid: 3214753
references.citation: Neuropsychopharmacology. 1992 May;6(3):145-53
references.pmid: 1599605
references.citation: J Pharmacol Exp Ther. 1983 Oct;227(1):167-73
references.pmid: 6194284
references.citation: J Clin Invest. 1986 Jan;77(1):222-7
references.pmid: 3003150
references.citation: Neurosci Lett. 1984 Jun 15;47(2):91-8
references.pmid: 6205333
references.citation: J Pharmacol Exp Ther. 1993 Sep;266(3):1268-76
references.pmid: 8371136
references.citation: Neuroscience. 1992 Dec;51(3):501-12
references.pmid: 1488111
references.citation: Brain Res. 1992 Oct 23;594(1):124-30
references.pmid: 1467931
references.citation: J Med Chem. 1992 Feb 7;35(3):407-22
references.pmid: 1738138
references.citation: Pharmacol Biochem Behav. 1988 Feb;29(2):411-8
references.pmid: 3362935
references.citation: Eur J Pharmacol. 1994 Feb 21;253(1-2):95-9
references.pmid: 8013554
references.citation: Life Sci. 1983 Aug 22;33(8):779-87
references.pmid: 6888193
references.citation: FEBS Lett. 1993 May 24;323(1-2):141-4
references.pmid: 8495727
references.citation: Proc Natl Acad Sci U S A. 1981 May;78(5):3260-4
references.pmid: 6265942
references.citation: Biochem Pharmacol. 1987 Aug 1;36(15):2533-8
references.pmid: 3606653